Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Share-based Compensation (2016 - 2025)

STRATA Skin Sciences' Share-based Compensation history spans 14 years, with the latest figure at $212000.0 for Q3 2025.

  • For Q3 2025, Share-based Compensation rose 715.38% year-over-year to $212000.0; the TTM value through Sep 2025 reached $595000.0, up 0.85%, while the annual FY2024 figure was $427000.0, 67.23% down from the prior year.
  • Share-based Compensation for Q3 2025 was $212000.0 at STRATA Skin Sciences, up from $128000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $662000.0 in Q1 2021 and bottomed at $26000.0 in Q3 2024.
  • The 5-year median for Share-based Compensation is $289000.0 (2023), against an average of $279368.4.
  • The largest annual shift saw Share-based Compensation crashed 92.28% in 2024 before it surged 715.38% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $80000.0 in 2021, then skyrocketed by 138.75% to $191000.0 in 2022, then skyrocketed by 51.31% to $289000.0 in 2023, then plummeted by 56.4% to $126000.0 in 2024, then soared by 68.25% to $212000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Share-based Compensation are $212000.0 (Q3 2025), $128000.0 (Q2 2025), and $129000.0 (Q1 2025).